Education
About Us
Working with TipRanks
Follow Us
Hutchmed (China) Limited (HCM)
:HCM
HCM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$11.51 - $21.50
Previous CloseN/A
Volume23.53K
Average Volume (3M)87.96K
Market Cap
$2.84B
Enterprise Value$12.23B
Total Cash (Recent Filing)$836.11M
Total Debt (Recent Filing)$89.82M
Price to Earnings (P/E)74.2
Beta0.31
Next Earnings
Aug 07, 2025EPS Estimate
1.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding174,422,290
10 Day Avg. Volume78,481
30 Day Avg. Volume87,960
Financial Highlights & Ratios
PEG Ratio-0.47
Price to Book (P/B)20.51
Price to Sales (P/S)0.00
P/FCF Ratio-41.02
Enterprise Value/Market Cap4.31
Enterprise Value/Revenue4.73
Enterprise Value/Gross Profit176.73
Enterprise Value/Ebitda-48.14
Forecast
1Y Price Target
$20.85Price Target Upside29.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
HUTCHMED News
PremiumCompany Announcements
Hutchmed Reports Strong 2024 Growth and Profitability
Ownership Overview
―
Insiders
0.04% Mutual Funds
0.62% Other Institutional Investors
99.26% Public Companies and
Individual Investors
HCM FAQ
What was Hutchmed (China) Limited’s price range in the past 12 months?
Hutchmed (China) Limited lowest stock price was $11.51 and its highest was $21.50 in the past 12 months.
What is Hutchmed (China) Limited’s market cap?
Hutchmed (China) Limited’s market cap is $2.84B.
When is Hutchmed (China) Limited’s upcoming earnings report date?
Hutchmed (China) Limited’s upcoming earnings report date is Aug 07, 2025 which is in 23 days.
How were Hutchmed (China) Limited’s earnings last quarter?
Currently, no data Available
Is Hutchmed (China) Limited overvalued?
According to Wall Street analysts Hutchmed (China) Limited’s price is currently Undervalued.
Does Hutchmed (China) Limited pay dividends?
Hutchmed (China) Limited does not currently pay dividends.
What is Hutchmed (China) Limited’s EPS estimate?
Hutchmed (China) Limited’s EPS estimate is 1.42.
How many shares outstanding does Hutchmed (China) Limited have?
Hutchmed (China) Limited has 174,422,290 shares outstanding.
What happened to Hutchmed (China) Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Hutchmed (China) Limited?
Currently, no hedge funds are holding shares in HCM
HUTCHMED Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$20.85 (29.99% Upside)
$20.85 (29.99% Upside)
Blogger Sentiment
Bullish
HCM Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 110.4K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.78%
12-Months-Change
Fundamentals
Return on Equity
5.06%
Trailing 12-Months
Asset Growth
-0.44%
Trailing 12-Months
Company Description
Hutchmed (China) Limited
HUTCHMED (HCM) is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapeutics and immunotherapies for the treatment of cancer and immunological diseases. Operating primarily in the healthcare and pharmaceutical sectors, the company focuses on developing innovative oncology and immunology drugs, with a strong pipeline of product candidates and several marketed products. HUTCHMED integrates its research and development capabilities with commercial operations to deliver innovative healthcare solutions.
HCM Stock 12 Month Forecast
Average Price Target
$20.85
▲(29.99%Upside)
Technical Analysis
Dynavax
―
Perrigo Company
―
Supernus Pharmaceuticals
―
Amneal Pharmaceuticals
―
Alvotech
―